Summary.
We previously reported that the use of a specifically designed Wearing-Off Questionnaire (WOQ) identified symptoms of wearing-off more frequently than standard assessments conducted by movement disorder specialists during a routine office visit. In the previous study we used a WOQ of 32 symptoms; however this tool was not designed for daily use. In this paper we describe the retrospective development of a simpler, 19-symptom WOQ more suitable for routine clinical use.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Y Agid CW Olanow Y Mizuno (2002) ArticleTitleLevodopa: why the controversy Lancet 360 575 Occurrence Handle12241695 Occurrence Handle10.1016/S0140-6736(02)09733-7 Occurrence Handle1:STN:280:DC%2BD38vnvVShuw%3D%3D
JE Ahlskog MD Muenter (2001) ArticleTitleFrequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature Mov Disord 16 448–458 Occurrence Handle11391738 Occurrence Handle10.1002/mds.1090 Occurrence Handle1:STN:280:DC%2BD3MzitVCmtg%3D%3D
KR Chaudhuri L Yates P Martinez-Martin (2005) ArticleTitleThe non-motor symptom complex of Parkinson’s disease: a comprehensive assessment is essential Curr Neurol Neurosci Rep 5 275–283 Occurrence Handle15987611
RC Dodel K Berger WH Oertel (2001) ArticleTitleHealth-related quality of life and healthcare utilisation in patients with Parkinson’s disease: impact of motor fluctuations and dyskinesias Pharmacoeconomics 19 1013–1038 Occurrence Handle11735671 Occurrence Handle10.2165/00019053-200119100-00004 Occurrence Handle1:STN:280:DC%2BD38%2Fjtlaruw%3D%3D
CG Goetz W Poewe O Rascol C Sampaio (2005) ArticleTitleEvidence-based medical review update: pharmacological and surgical treatments of Parkinson’s disease: 2001 to 2004 Mov Disord 20 523–539 Occurrence Handle15818599 Occurrence Handle10.1002/mds.20464
CD Marsden JD Parkes (1977) ArticleTitleSuccess and problems of long-term levodopa therapy in Parkinson’s disease Lancet 1 345–349 Occurrence Handle64868 Occurrence Handle10.1016/S0140-6736(77)91146-1 Occurrence Handle1:STN:280:CSiD1MbhtVU%3D
CW Olanow F Stocchi (2004) ArticleTitleCOMT inhibitors in Parkinson’s disease: can they prevent and/or reverse levodopa-induced motor complications? Neurology 62 IssueIDSuppl 1 S72–S81 Occurrence Handle14718683 Occurrence Handle1:CAS:528:DC%2BD2cXhsFWgtbs%3D
InstitutionalAuthorNameParkinson Study Group (1996) ArticleTitleImpact of deprenyl and tocopherol treatment on Parkinson’s disease in DATATOP patients not requiring levodopa Ann Neurol 39 29–36 Occurrence Handle10.1002/ana.410390106
InstitutionalAuthorNameParkinson Study Group (2000) ArticleTitlePramipexole vs. levodopa as initial treatment for Parkinson disease: A randomized controlled trial JAMA 284 1931–1938 Occurrence Handle10.1001/jama.284.15.1931
M Stacy A Bowron M Guttman R Hauser K Hughes JP Larsen et al. (2005) ArticleTitleIdentification of motor and nonmotor wearing-off in Parkinson’s disease: Comparison of a patient questionnaire versus a clinician assessment Mov Disord 20 726–733 Occurrence Handle15719426 Occurrence Handle10.1002/mds.20383
K Thomas J Samanta P Mahant K Williamson M Stacy (2002) ArticleTitleThe Ali Project: A web-based database for Parkinson’s disease Mov Disord 17 IssueID[Suppl 5] S141
InstitutionalAuthorNameUPDRS Taskforce (2003) ArticleTitleThe Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations Mov Disord 18 738–750 Occurrence Handle10.1002/mds.10473
M Welsh MP McDermott RG Holloway S Plumb R Pfeiffer J Hubble (2003) ArticleTitleDevelopment and testing of the Parkinson’s disease quality of life scale Mov Disord 18 637–645 Occurrence Handle12784266 Occurrence Handle10.1002/mds.10424
T Witjas E Kaphan JP Azulay O Blin M Ceccaldi J Pouget et al. (2002) ArticleTitleNonmotor fluctuations in Parkinson’s disease: frequent and disabling Neurology 59 408–413 Occurrence Handle12177375
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stacy, M., Hauser, R. Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson’s disease. J Neural Transm 114, 211–217 (2007). https://doi.org/10.1007/s00702-006-0554-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-006-0554-y